The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2015
Filed:
Jul. 19, 2011
Applicants:
Jean-francois Zagury, Paris, FR;
Matthieu Montes, Paris, FR;
Hadley Mouhsine, Kremlin Bicetre, FR;
Helene Guillemain, Conflans Sainte Honorine, FR;
Inventors:
Jean-Francois Zagury, Paris, FR;
Matthieu Montes, Paris, FR;
Hadley Mouhsine, Kremlin Bicetre, FR;
Helene Guillemain, Conflans Sainte Honorine, FR;
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 45/06 (2006.01); A61K 31/343 (2006.01); A61K 31/495 (2006.01); A61K 31/502 (2006.01); A61K 31/18 (2006.01); A61K 31/352 (2006.01); A61K 31/403 (2006.01); C07C 311/21 (2006.01); C07C 311/29 (2006.01); C07D 207/38 (2006.01); C07D 207/48 (2006.01); C07D 295/185 (2006.01); C07D 295/215 (2006.01); C07D 295/26 (2006.01); C07D 307/79 (2006.01); C07D 307/91 (2006.01); C07D 307/92 (2006.01); C07D 309/38 (2006.01); C07D 317/66 (2006.01); C07D 319/18 (2006.01); C07D 405/12 (2006.01); C07D 237/34 (2006.01); C07D 241/04 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 2121/00 (2013.01); A61K 31/18 (2013.01); A61K 31/343 (2013.01); A61K 31/352 (2013.01); A61K 31/403 (2013.01); A61K 31/495 (2013.01); A61K 31/502 (2013.01); C07C 311/21 (2013.01); C07C 311/29 (2013.01); C07C 2103/20 (2013.01); C07D 207/38 (2013.01); C07D 207/48 (2013.01); C07D 295/185 (2013.01); C07D 295/215 (2013.01); C07D 295/26 (2013.01); C07D 307/79 (2013.01); C07D 307/91 (2013.01); C07D 307/92 (2013.01); C07D 309/38 (2013.01); C07D 317/66 (2013.01); C07D 319/18 (2013.01); C07D 405/12 (2013.01); C07D 237/34 (2013.01); C07D 241/04 (2013.01);
Abstract
A benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids, for its use in a method for treating a pathology linked to an excessive effect of TNF-alpha and for its use in a method for treating the human or animal body as a direct inhibitor of TNF-alpha.